Slovakia: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Slovakia

In 2021, after three years of growth, there was significant decline in the Slovak market for medicaments of alkaloids or derivatives thereof, when its value decreased by -X% to $X. Over the period under review, consumption, however, continues to indicate a buoyant increase. Over the period under review, the market hit record highs at $X in 2020, and then declined in the following year.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in Slovakia

In value terms, production of medicaments of alkaloids or derivatives thereof contracted to $X in 2021 estimated in export price. Over the period under review, production, however, enjoyed buoyant growth. The growth pace was the most rapid in 2018 with an increase of X%. Production of peaked at $X in 2020, and then contracted in the following year.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from Slovakia

For the third consecutive year, Slovakia recorded decline in shipments abroad of medicaments of alkaloids or derivatives thereof, which decreased by -X% to X tons in 2019. Overall, exports continue to indicate a abrupt descent. The growth pace was the most rapid in 2014 when exports increased by X% against the previous year. As a result, the exports attained the peak of X tons. From 2015 to 2019, the growth of the exports of failed to regain momentum.

In value terms, exports of medicaments of alkaloids or derivatives thereof fell to $X in 2019. The total export value increased at an average annual rate of +X% from 2012 to 2019; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2016 when exports increased by X%. As a result, the exports reached the peak of $X. From 2017 to 2019, the growth of the exports of remained at a somewhat lower figure.

Exports by Country

The UK (X tons), Hungary (X tons) and Lithuania (X tons) were the main destinations of exports of medicaments of alkaloids or derivatives thereof from Slovakia, together accounting for X% of total exports. Poland, Kazakhstan, the Czech Republic, Russia, Romania, Latvia and Bulgaria lagged somewhat behind, together comprising a further X 2012 to 2019, the biggest increases were in Kazakhstan (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Lithuania ($X) remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from Slovakia, comprising X% of total exports. The second position in the ranking was taken by Hungary ($X), with an X% share of total exports. It was followed by the Czech Republic, with a X% share.

From 2012 to 2019, the average annual growth rate of value to Lithuania stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Hungary (-X% per year) and the Czech Republic (-X% per year).

Export Prices by Country

The average export price for medicaments of alkaloids or derivatives thereof stood at $X per ton in 2019, picking up by X% against the previous year. Overall, the export price enjoyed prominent growth. The pace of growth was the most pronounced in 2016 an increase of X%. The export price peaked in 2019 and is likely to see steady growth in years to come.

There were significant differences in the average prices for the major external markets. In 2019, the country with the highest price was Lithuania ($X per ton), while the average price for exports to Kazakhstan ($X per ton) was amongst the lowest.

From 2012 to 2019, the most notable rate of growth in terms of prices was recorded for supplies to Lithuania (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into Slovakia

In 2019, overseas purchases of medicaments of alkaloids or derivatives thereof decreased by -X% to X tons, falling for the second year in a row after two years of growth. Over the period under review, imports, however, enjoyed a buoyant expansion. The most prominent rate of growth was recorded in 2014 when imports increased by X%. Over the period under review, imports of reached the maximum at X tons in 2017; however, from 2018 to 2019, imports failed to regain momentum.

In value terms, imports of medicaments of alkaloids or derivatives thereof reduced to $X in 2019. In general, imports continue to indicate a deep setback. The pace of growth was the most pronounced in 2016 with an increase of X% against the previous year. Over the period under review, imports of hit record highs at $X in 2012; however, from 2013 to 2019, imports remained at a lower figure.

Imports by Country

In 2019, the Czech Republic (X tons) constituted the largest medicaments of alkaloids or derivatives thereof supplier to Slovakia, with a X% share of total imports. Moreover, imports of medicaments of alkaloids or derivatives thereof from the Czech Republic exceeded the figures recorded by the second-largest supplier, the United States (X tons), fourfold. The third position in this ranking was taken by the Netherlands (X tons), with a X% share.

From 2012 to 2019, the average annual growth rate of volume from the Czech Republic stood at +X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (+X% per year) and the Netherlands (+X% per year).

In value terms, the United States ($X) constituted the largest supplier of medicaments of alkaloids or derivatives thereof to Slovakia, comprising X% of total imports. The second position in the ranking was taken by the Netherlands ($X), with a X% share of total imports. It was followed by the Czech Republic, with a X% share.

From 2012 to 2019, the average annual growth rate of value from the United States stood at +X%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (+X% per year) and the Czech Republic (-X% per year).

Import Prices by Country

In 2019, the average import price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, flattening at the previous year. In general, the import price, however, continues to indicate a deep downturn. The growth pace was the most rapid in 2016 an increase of X%. Over the period under review, average import prices reached the maximum at $X per ton in 2012; however, from 2013 to 2019, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2019, the country with the highest price was France ($X per ton), while the price for the Czech Republic ($X per ton) was amongst the lowest.

From 2012 to 2019, the most notable rate of growth in terms of prices was attained by Germany (+X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :